New Delhi: Aiming to develop affordable vaccines for global health, pharmaceutical firm Hilleman Laboratories on Friday said it has successfully completed the initial clinical trials of its novel oral cholera vaccine Hillchol. The vaccine, once ready for use, will address the growing need to stop cholera in the developing world. “The Phase I/II clinical […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.